Skip to main content
SpringerLink
Log in

Ciclesonide: profile report

  • Drugs and Profile Report
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement.

References

  1. Reynolds NA, Scott LJ. Ciclesonide. Drug 2004; 64(5): 511–9

    Article  CAS  Google Scholar 

  2. Belvisi MG. Ciclesonide: a viewpoint. Drugs 2004; 64(5): 520

    Article  Google Scholar 

  3. Schlosser NJJ. Ciclesonide: a viewpoint. Drugs 2004; 64(5): 520–1

    Article  Google Scholar 

  4. British Thoracic Society. Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Thorax 2003 Feb; 58 Suppl. 1: 1–94

    Google Scholar 

  5. Tattersfield AE, Knox AJ, Britton JR, et al. Asthma. Lancet 2002 Oct; 360: 1313–22

    Article  PubMed  CAS  Google Scholar 

  6. National Heart, Lung and Blood Institute. Expert panel report: guidelines for the diagnosis and management of asthma —update on selected topics 2002. J Allergy Clin Immunol 2002 Nov; 110(5): S141–219

    Article  Google Scholar 

  7. Hansel T, Engelstatter R, Benezet O, et al. Once daily ciclesonide (80µg or 320µg) is equally effective as budesonide 200µg given twice daily: a 12-week study in asthma patients [abstract no. P2639]. Eur Respir J 2003; 22 Suppl. 45: 410. Plus poster presented at the 13th Annual Congress of the European Respiratory Society; 2003 Sep 27–Oct 1; Vienna

    Google Scholar 

  8. Ukena D, Biberger C, von Behren V, et al. Ciclesonide significantly improves pulmonary function when compared with budesonide: a randomized 12-week study [abstract no. P2640]. Eur Respir J 2003; 22 Suppl. 45: S45. Plus poster presented at the 13th Annual Congress of the European Respiratory Society; 2003 Sep 27–Oct 1; Vienna

    Google Scholar 

  9. Boulet L-P, Engelstatter R, Magyar P, et al. Ciclesonide is at least as effective as budesonide in the treatment of patients with bronchial asthma [abstract no. A1508]. Am J Respir Crit Care Med 2003; 167. Plus poster presented at the 99th International Conference of the American Thoracic Society; 2003 May 16–21; Seattle

  10. O’Connor BJ, Kilfeather S, Cheung D, et al. Treatment of moderate to severe asthma with ciclesonide: a long-term investigation over 52 weeks [abstract no. 2579]. Eur Respir J 2002 Sep; 20 Suppl. 38: 406s

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ciclesonide: profile report. Drugs Ther. Perspect 20, 5–6 (2004). https://doi.org/10.2165/00042310-200420070-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420070-00002

Search

Navigation